Abstract
Purpose To report a case of culture-positive endophthalmitis after intravitreal injection of bevacizumab (Avastin) resulting in a devastating visual outcome. Method A retrospective case report of a 51-year-old diabetic women who presented with further decrease in her vision, redness, and mild pain in her eye 3 days after intravitreal injection of Avastin for macular edema due to a branch retinal vein occlusion. Results Clinical diagnosis of endophthalmitis was made and, after obtaining a vitreous tap, intravitreal antibiotics were administered. Because of worsening of the endophthalmitis, pars plana vitrectomy was undertaken followed by repeat intravitreal antibiotics injection. The patient’s ocular condition improved dramatically; however, her visual acuity did not improve. The cultures from vitreous taps revealed Staphylococcus lugdunesis. Conclusion Intravitreal injection of Avastin may be associated with a risk of S. lugdunesis-caused endophthalmitis which can have a devastating effect on the final visual outcome.
This is a preview of subscription content, log in via an institution to check access.
References
Ferrara N, Hillan KJ, Gerber HP et al (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3:391–400
Melvin DR, Dante JP, Alessandero AC et al (2007) Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondry to branch retinal vein occlusion. Retina 27:419–425
Jaissle GB, Ziemssn F, Petermeier K et al (2006) Bevacizumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 113:363–372
Iturralde D, Spaid RF, Mayerle CB et al (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26:279–284
Rosenfeld PJ, Fung AE, Puliafito CA (2005) Optical coherence tomography finding after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36:336–339
Jonas JB, Spandau UH, Rensch F (2007) Infectious and noninfectious endophthalmitis after intravitreal bevacizumab. J Ocul Pharmacol Ther 23:240–242
Fung AE, Rosenfeld PJ, Reichel E (2006) The international intravitreal bevacizumab safety survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90:1344–1349
Aggio FB, Farah ME, de Melo GB et al (2007) Acute endophthalmitis following intravitreal bevacizumab (Avastin) injection. Eye 21:408–409
Chiquet C, Pechinot A, Creuzot-Garcher C et al (2007) Acute postoperative endophthalmitis caused by Staphylococcus lugdunesis. J Clin Microbiol 45:1673–1678
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alkuraya, H.S., Al-kharashi, A.S., Alharthi, E. et al. Acute endophthalmitis caused by Staphylococcus lugdunesis after intravitreal bevacizumab (Avastin) injection. Int Ophthalmol 29, 411–413 (2009). https://doi.org/10.1007/s10792-008-9237-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-008-9237-z